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Abstract 
 
Research has shown that older individuals are far more 
likely to avail of health care and there is concern in a 
number of countries that the trend toward population 
ageing may mean that health care expenditures increase 
to unsustainable levels. However, there is a growing 
body of evidence that the approach of death rather than 
age per se may be the main determinant of health care 
costs. Previous analyses of the relationship between 
proximity to death and costs have used rare longitudinal 
data on costs and whether died and none have used a 
national sample. In this paper we use a more commonly 
found data type – a national panel survey to show that 
proximity to death is indeed a more significant predictor 
of expenditure on GP and hospital services than age. 
Using random effects panel models we show that there 
is a significant gradient in costs as death approaches. 
Controlling for proximity to death there is no age gradient 
in costs. This conclusion remains unchanged adjusting 
for differential health inpatient costs across age groups. 
In fact, adjustment steepens the gradient in costs as 
death approaches.  
 
 
1. Introduction 
 
There is now agreement that population ageing is already a serious 
issue and will be significant in industrialised economies over future decades 
[1]. For example, within the 15 countries of the EU before May 2004 the 
number of people aged over 65 has increased from 34 million in 1960 to 60 
million by 1999 (2)]. Those aged eighty or more are the fastest growing 
population group with numbers predicted to increase by almost 50% in the EU 
15 over the next fifteen years. What is less well established is the impact that 
population ageing will have on health care expenditures. Age is certainly 
related to increased use of health care services [3] and this is reflected in 
higher per capita health care expenditures on older age groups [4]. Yet 
comparative studies have failed to find a relationship between the population 
share of older people and country per capita health care expenditure [5]. 
Instead there is a growing body of research which suggests that health care 
costs are actually a function of proximity to death rather than age per se. For 
example, Zweifel et al [6] used data on costs in the last two years of life from 
two sickness funds in Switzerland to show that age was largely irrelevant as a 
determinant of health care expenditure in the last two years of life, while the 
final three months was highly significant. Controlling for proximity to death 
there was no significant increase in expenditure by age. 
 Further evidence of the relationship between end of life and health care 
costs was provided by O’Neill et al [7] using a sample of 270 individuals aged 
65 or more in the Nottingham Health Authority Area in the UK. This study 
found that those individuals in their last year of life were significantly more 
expensive to care for than those who survived the duration of the study, but 
age was not a significant factor in level of costs. The study also showed that 
among those who died during the study, costs were unrelated to age but were 
significantly related to proximity to death. 
 Both Zweifel et al and O’Neill offer evidence of a relationship but both 
have the limitation of observing the relationship between closeness to death 
and costs over a relatively short time frame. This was rectified in Seshamani 
and Gray [8] which used data from the Oxford Record Linkage Study (ORLS) 
from 1970 to 1999 to track hospital costs among a sample of almost 96,000 
individuals in the Oxfordshire area of England. The study used a two-step 
methodology (unlike Zweifel et al, without Heckman correction) and random-
effects models to show that costs increase up to 15 years prior to death. 
Moreover, the tenfold increase in costs in the final 5 years of life easily 
outweighed the 30% increase in costs which occurred between age 65 and 
85.  
 Seshamani and Gray [8] provide compelling evidence for a region of 
Great Britain, but data such as that found in the Oxford Record Linkage Study 
are rare. In this paper we look to confirm the findings of Seshamani and Gray 
at the country level using data from a national panel survey – the Living in 
Ireland Panel Survey (LII), which is the Irish component of the European 
Community Household Panel Survey (ECHP). By selecting individuals who 
died within the panel observation period and examining their previous health 
care utilisation we are able to put a value on the costs of care as death 
approaches whilst controlling for the age of the individual. Unlike Seshamani 
and Gray we cannot examine the average yearly cost of the approach of 
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death as only a small proportion of those in our panel data died, but we are 
able to examine the hypothesis that health care expenditure is more closely 
linked to the proximity of the individual to death rather than their age over a 
substantial period of seven years and for a nationally representative 
population.   
  
2. Data 
 
For this paper we use data from the Living in Ireland (LII) survey which 
includes the Irish component of the European Community Household Panel 
Survey, but has a substantially enhanced range of questions and an 
enhanced sample size from 2000 on. The survey began in 1994 and 
respondents were followed every year thereafter until 2001. The LII is based 
on a two-stage clustered random probability sample which began with a 
sample of 4048 households and 9904 individuals (a 63% response rate at the 
individual level). The rate of subsequent non-response was heaviest in 1995, 
but continued to occur through to the final year used in this paper 2001. In 
1995, 89% of the original completed households (3584) and 86% of the 
original individuals (8532) were reinterviewed, although some households and 
individuals were rerecruited in subsequent years. By 1999 the number of 
households had been reduced to 2378 and individuals to 5451 so the decision 
was made to supplement the sample. This led to the addition of 2661 
households and 3527 individuals in 2000 leading to a total sample of 5027 
households and 8056 individuals. It is not necessary that the individuals who 
die in the sample be in the sample for all eight years of the observation 
period. As we will go onto show, our aim is to estimate the costs of being N 
years from death controlling for age and other factors and for this we simply 
need observations of health care costs and other characteristics for those who 
subsequently die. We are in this sense analysing ‘person periods’ rather than 
persons. 
 The data extracted for use in this paper contain 53,665 person periods 
of a single year collected from 15,483 individuals who took part in the LII 
survey between 1994 and 2001. As shown in Table 1, during that period there 
where 456 deaths registered among the survey sample of which 192 were 
women and 264 were men. Not unexpectedly, average age among the 
sample (the mean age of the person, not person periods) who did not survive 
was considerably higher than among survivors at 72 compared to 41. Mean 
age at death for the former was 73 for men and 74 for women.  
 It is crucial to find out whether the LII data gives us a representative 
picture of the number of deaths and the costs of care preceding this. Statistics 
from the Irish Central Statistics Office (CSO) show that deaths among those 
aged 20 or more were 1.3% of total in 1996 falling to 1.1% in 2001. Death 
rates in the LII sample were only slightly less than this at between 1.1% and 
1% of sample through the period. The LII survey was of private households 
and would not then interview the 0.9% of the Irish population who are in long-
term residential care and this, plus some measurement error, probably 
accounts for slight difference between the death rates in the LII sample and 
those from national death registers.  
The LII survey has a greater range of measures and indicators than the 
ECHP survey and it is possible to find out if a person had died even if the 
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household record lapsed with their passing. Combined with the fact that older 
people were more likely to remain in the sample through the observation 
period this meant that we are able to detect and register the overwhelming 
proportion of deaths in the sample.   
 Another check we can perform on the data is a comparison of the age 
of those deaths that occur in the LII sample compared to national Irish 
statistics. Table 1 shows that the pattern of age at death in the LII data largely 
follows those of data published by the CSO with the largest proportion of 
deaths occurring in the 75-84 age group. 
 
Table 1: Age at Death in LII & CSO 
Statistics 
 LII CSO* 
Aged <65 20.0% 18.6% 
65-74 21.5% 23.1% 
75-84 41.2% 35.9% 
85+ 17.3% 22.5% 
Total 100% 100% 
* Deaths by age group in 1996 
 
 Before we turn to the multivariate analyses it is useful to get a 
descriptive overview of differences in health care usage between those 
respondents who died within the survey observation window (“descendents”) 
and those that did not (“survivors”). Table 2 gives summary statistics on 
usage of GP, hospital and specialist/consultant services. It is clear from this 
that descendents who died within the panel observation period were heavier 
users of hospital and GP services.  
 
Table 2: Descriptive Statistics of Surviving and Non-Surviving Samples 
Mean (std in parentheses) Men Women Both 
Survivors    
N Persons 7,462 7,563 15,025 
N Person Periods 25,975 26,173 52,148 
Age 41.79 (17.71) 43.19(18.03) 42.49(17.88) 
Hospital Nights per year 0.95 (7.14) 1.15(6.49) 1.05(6.82) 
GP Visits 2.84 (5.28) 4.23(6.23) 3.54(5.81) 
Specialist Visits 0.42 (2.05) 0.60(3.3) 0.51(2.75) 
Total Costs per year 482.57(2495.73) 626.55(2356.24) 554.83(2427.77) 
    
Descendents    
N Persons 265 193 458 
N Person Periods 879 638 1,517 
Age 71.43(13.49) 72.11(13.83) 71.72(13.63) 
Hospital Nights per year 4.35(13.68) 7.19(20.15) 5.54(16.76) 
GP Visits per year 7.89(9.16) 10.26(9.98) 8.89(9.58) 
Specialist Visits per year 0.69(2.19) 0.88(2.14) 0.77(2.17) 
Total Costs per year 1801.17(4627.36) 2837.01(6745.98) 2236.81(5637.78)
Age at Death 72.71(13.70) 74.21(13.58)  73.34(13.66) 
 
Whereas survivors had just over 1 night in hospital on average, descendents 
had over 5. Survivors had almost 4 GP visits per year on average whereas 
descendents had over almost 9. The difference between the groups is less 
 3 
 
marked for visits to a medical specialist with survivors having around 0.5 
specialist visits on average per year compared to 0.77 visits for descendents.  
On average then, those individuals who died during the panel 
observation period where heavier users of GP and hospital services. This is 
likely to mean that those who died during the panel were also more costly 
users of healthcare, but it is not possible to say this conclusively until we have 
a measure of cost. A previous paper Layte and Nolan 2004 developed cost 
estimates for different types of healthcare in Ireland for the year 2000 using a 
range of methods and here we use this previous work to develop an estimate 
of the cost of healthcare used by each individual in each year. Layte and 
Nolan [9] estimated that a GP visit cost €32.25, a night in hospital €325.12 
and a visit to a specialist €193.50 in 2000. These relativities between the 
different types of health care may well have changed between 1994 and 
2001, but for the purposes of this paper it is sufficient to apply these estimates 
to usage over the whole so as to get a stable measure for comparative 
purposes. It would hamper rather than help analysis if we have to take 
account of changing relativities between types over the period.  
 A more serious issue may be the possibility that we may in fact under-
estimate the cost difference between those who survive the period and those 
who do not. Although the severity of the illness may not influence the cost of 
GP visits, it could increase the cost of specialist visits where certain 
specialities such as oncology and cardiology are more expensive. Similarly, 
hospital inpatient costs may vary significantly along a number of dimensions 
such as final outcome (death, survival), age and other socio-demographic 
variables.  
In this paper we first produce initial estimates of the impact of age and 
proximity to death based solely upon the frequency of utilisation (section 
Four). In Section Five we then adjust for the differential costs of inpatient care 
using data from the Hospital In Patient Enquiry system data file that collects 
information on hospital discharges in Ireland. This includes a measure of the 
‘relative value’ of in patient care compared to the average as well as a number 
of other variables. We use this data to produce estimates of the costs of 
utilisation in the ECHP data (see below).  
  Before we go onto directly assess this hypothesis it is useful first to 
examine the relationship between cost and age on a descriptive basis to 
assess whether dying is associated with a higher cost across age groups and 
if so whether this difference is uniform. Unfortunately the relatively small 
number of deaths in the sample, particularly at younger ages means that we 
are not able to examine cost differences under the age of 45 between those 
who died and those who did not. However, Figure 1 shows that for both those 
who survived and those who died that the cost of healthcare rises with age, 
although the patterns are somewhat different for men and women and 
between those who died and those who survived. Those who died had a 
higher level of health care costs at each age than those who survived, but the 
difference is larger for women than men. Men and women who survived have 
very similar levels of healthcare costs across the age range except for the 
oldest group where the mean for men increases substantially. Among women 
who died there is a pronounced peak in the 55 to 64 year age group. This 
pattern may simply be an artefact of the relatively small number of cases that 
we have available for analysis, but it could also represent a real trend in costs.  
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Figure 1: Mean Cost of Healthcare by Age Group and 
Whether Died in Panel
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It may be for example, that conditions which occur after considerable lifetime 
exposure to particular lifestyles or circumstances such as heart disease or 
cancer, emerge around this age and lead to both excess premature death and 
costs. However, it is difficult to see why this peak would occur for women and 
not men. 
 Overall Figure 1 supports the hypothesis that healthcare costs are 
increased by the approach of death, although we cannot tell if costs increase 
as death approaches or whether those who subsequently die within each age 
group have higher healthcare costs generally. To examine whether we see an 
increase in the cost of care as death approaches controlling for age we need 
to specify a model of the process that takes into account the panel structure of 
the data. It is to this that we turn in the following section.  
 
3. Methods 
 
The methodology that we use for analysis is partially dictated by our 
aims in the paper and partially by the LII data on deaths. A number of 
researchers have advocated a two-step approach [10][11] to modelling health 
care utilisation as the most appropriate way of analysing the decision-making 
process underlying the final outcome. The argument is that the initial decision 
to use a service is different from the decision about how frequently to do so 
and so the two-stages should be modelled separately. This is often necessary 
because a large proportion of most samples will not have incurred health care 
costs, especially if hospital inpatient care is being studied. In our data 
however, we have very few zero observations for healthcare costs. Although 
89 of the 458 (10% of person periods and just over 19% of persons) 
respondents who died have at least one year in which they used none of the 
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three health care types we examine across the eight-year observation 
window, just twelve incurred no healthcare costs across the entire period they 
were present in the survey. We thus choose to use a single-step procedure. 
Our data are derived from a panel survey and this introduces an added 
complexity since a cross-sectional framework may not control for individual-
specific effects. Given this we choose to use a random-effects model which 
fits an unobserved individual-specific error term εi with a zero mean and 
normal (Gaussian) distribution. As is often found with health care expenditure 
the sample distribution has a long right tail which produces a skew coefficient 
of 6.28. A natural log transformation reduces this to 0.42 and we use this form 
in the equation estimating healthcare costs: 
 
1. Log(HCE)= αi+β1Ait+β2Sit +β3YBDit+β4Mit+β5HEit+β6YRit+εi
 
Where A: Age, S: Female, YBD: Years before death, M: Marital Status, HE: 
Highest Education, YR: Calendar Year, εi: individual level error term.  
We confine analyses in this section to the 458 of 15,017 respondents 
to the LII panel survey for whom we have a year of death. Exclusion of zero 
cost observations and missing data reduces the sample to 1,357 periods and 
444 individuals. As individuals may have been observed for different lengths 
of time it is possible that this introduces selection bias [12]. To test for such 
bias we introduced variables into equation 1 for total number of time periods 
of observation and its square [12]. Both variables were insignificant showing 
that selection bias would not substantially affect our panel models. 
  
4. Results 
 
 Table 3 gives the results for a random effects GLS regression of the 
log(costs). The coefficient rho in the final line of Table 3 shows that the panel 
level variance component contributes 36% of total variance. This underlines 
the importance of using a method of analysis appropriate for panel data. 
The results show that there is a pronounced gradient in the impact of 
year before death ln(cost) of healthcare rises significantly as death 
approaches controlling for age. The effects for age on the other hand are not 
significant. It would be useful to examine whether the costs of proximity to 
death increase in older age groups but given the relatively small number of 
cases available to us it is not possible to interact age with proximity to death 
and so this analysis is not possible. Overall the results support our hypothesis 
that the costs of healthcare are a function of proximity to death rather than 
age per se.  
 It is possible to use the coefficients produced by the model of costs in 
Table 4 to create an estimate of the average cost of healthcare at N years 
before death setting other covariates at their mean. Simply retransforming the 
fitted estimates into costs in euros would introduce a retransformation bias 
[13], and so we follow Manning and Mullahy [14] and use a smearing 
estimator to correct for this. Using this approach Table 4 displays the 
corrected estimates for the marginal costs of healthcare N years before death. 
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Table 3: Linear Regression Model of ln(Cost) 
 β S.E 
2 Years Before Death -0.38** 0.11 
3 Years Before Death -0.29* 0.13 
4 Years Before Death -0.68*** 0.15 
5 Years Before Death -0.81*** 0.18 
6 Years Before Death -0.87*** 0.22 
7 Years Before Death -1.22*** 0.31 
Aged 65 to 74  0.10 0.17 
Aged 75 to 84 0.18 0.17 
Aged 85+ 0.31 0.23 
Female 0.39** 0.14 
Separated/Divorced  0.51** 0.18 
Widowed 0.86* 0.39 
Never Married  0.40* 0.20 
Lower Secondary 0.09 0.23 
Upper Secondary 0.02 0.26 
Tertiary 0.08 0.32 
1995  -0.08 0.11 
1996 -0.13 0.13 
1997 0.08 0.15 
1998 -0.02 0.18 
1999 0.13 0.22 
2000 0.06 0.25 
Constant 5.98*** 0.23 
N Persons 444  
N Periods 1357  
συ 1.36  
Ρ 0.36  
 
 This shows that costs rise across the seven-year period as death 
approaches in a steady upward progression. In the final four years of life 
average costs almost double from €1390 to €2755. As found by Seshamani & 
Gray we see a steepening of the slope in the final year of life, although unlike 
that paper the cost at two years to death is lower than at three years.  
 
Table 4: Predictions of Average Yearly 
Cost by Years Before Death 
Years Before Death Average Cost 
1 2754.57
2 1888.60
3 2066.76
4 1390.39
5 1220.00
6 1152.00
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7 813.80
  
This pattern may be a result of the much smaller sample used here than that 
used by Seshamani & Gray and that our results are for GP, specialist and 
hospital costs rather than just hospital costs.  
We can use the marginal effects calculated for the model in Table 3 to 
calculate the approximate impact of ageing on the costs of care compared to 
those shown in Table 4 for the years to death. Table 4 shows that there is an 
increase of €1942 between the seventh and final year of life whereas analysis 
of the age effects shows increases of €278 for those aged 65 to 74 compared 
to those aged 18 to 64, €540 for those 75 to 84 and €1014 for those aged 85 
or more.  
 
5. Adjusting for Differential Hospital Costs 
 
The above analyses indicate that the costs of health care increase as 
the person approaches death. Our measure of health care costs is based on 
the frequency of use and this may not be an accurate measure of health care 
costs if the value of utilisation varies significantly across the population. For 
example, Figure 2 shows the ‘relative value’ (RV) of discharges in Irish 
hospitals compared to the average in the year 2000 across age groups for 
survivors and descendents. This shows that the RV of treatment for 
descendents was considerably more on average than that for survivors, but 
that there was also considerable variation by age. Among survivors costs are 
relatively flat until the mid-30s after which there is a steady rise until age 70 
and a slight decline thereafter. For descendents on the other hand, the RV 
increases sharply until the mid-20s after which it falls steadily thereafter apart 
from a temporary rise between age 50 and 65. Both the peak in the mid 20s 
and the later rise are a consequence of the higher probability of expensive 
surgical treatments in these periods   
Figure 2: Average Hosptial Cost by Outcome and Age
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These changes in the relative value of discharges across age groups 
suggests that factoring differential cost into our estimates of expenditures may 
produce interesting results. Doing so, however, requires cost information for 
the person period data from the ECHP that is not available within the data file. 
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Instead we adopt an imputation procedure based on linking aggregate data 
from the Hospital Inpatient Enquiry (HIPE) system to the person periods of the 
ECHP. Although not ideal, this will allow us to make estimates of the role of 
differential costs across individuals. Of course, it is possible that health 
expenditures differ along a range of dimensions other than age and this is 
built into the linking procedure.  
We link the data by first, deriving the mean relative value of discharges 
within the HIPE data for groups defined by the cross-tabulation of the data by 
the variables sex, medical insurance status, medical card status and of 
course, grouped age. These means are based only on discharge records in 
the HIPE data for descendents. The values derived from this procedure are 
then matched to the person periods for descendents from the ECHP data 
using variables grouped in a similar manner. Total costs are then calculated 
by summing the cost figure for each inpatient night over the mean ‘rv’ for that 
individual. This value is then added to the existing values we derived for GP 
and outpatient care.  
Results show that adjusting for differential cost has some impact on the 
rate of increase in costs as death approaches as can be seen from Figure 3 
(full results are shown in the Appendix to the paper). This shows a steepening 
of the cost curve, particularly in the last year of life. Adjustment for differential 
cost does not change the effects found earlier in this paper for the impact of 
age.  
Figure 3: Health Care Expenditures by with and without 
Differential Hospital Costs
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 If we perform the same analysis of the impact of ageing verses that of 
proximity to death using the adjusted inpatient costs we find that being aged 
65 to 74 increases costs by €330 compared to those aged 18 to 64. For those 
aged 75 to 84 this increases to €620 and for those aged 85 plus to €1155. In 
comparison, Appendix Table 2 shows that the increase in cost between the 
seventh and last year of life is €2700. 
 
6. Discussion 
 
This paper has attempted to test the hypothesis that the costs of 
healthcare rise as a function of closeness to death rather than as a function of 
age. There is good evidence that older age is associated with a greater 
burden of chronic ill health and a higher usage healthcare services and this 
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would imply that the population ageing which most OECD countries will 
experience over the next half century will lead to an inexorable rise in the 
costs of health care as a larger and larger proportion of the population enter 
old age. However, if health care utilisation and costs are actually tied more 
strongly to the fact that a person is approaching death, irrespective of their 
age, then population ageing may not increase costs as steeply as previously 
suggested. This is not to say that costs will not increase at all however. As the 
numbers of individuals in their final five years of life increases this will 
inevitably increase the overall average expenditure on healthcare. Although 
we could not explicitly model the interaction of age with period to death, our 
analyses showed no statistically significant age gradient in costs for men or 
women, although the costs for women are significantly more than for men. If 
we calculate the net marginal affect of age relative to proximity to death the 
latter is almost three times at large. This differential remained even when we 
adjusted in patient costs to reflect differentials in expenditure associated with 
different age groups.   
This paper provides further evidence on the relationship between 
health care costs and proximity to death using a relatively long time period 
and a national sample. Large panel surveys are available for a number of 
other counties and it would be possible and useful to investigate the patterns 
found in these data also.   
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Appendix 
 
Table 1: Linear Regression Model of ln(Cost) 
 β S.E 
2 Years Before Death -0.39** 0.12 
3 Years Before Death -0.29* 0.13 
4 Years Before Death -0.70*** 0.16 
5 Years Before Death -0.83*** 0.19 
6 Years Before Death -0.89*** 0.23 
7 Years Before Death -1.25*** 0.32 
Aged 65 to 74  0.11 0.18 
Aged 75 to 84 0.20 0.18 
Aged 85+ 0.34 0.23 
Female 0.39** 0.14 
Separated/Divorced  0.53** 0.18 
Widowed 0.88* 0.40 
Never Married  0.41* 0.21 
Lower Secondary 0.08 0.24 
Upper Secondary 0.03 0.27 
Tertiary 0.09 0.33 
1995  -0.09 0.12 
1996 -0.13 0.13 
1997 0.07 0.15 
1998 -0.03 0.19 
1999 0.13 0.22 
2000 0.06 0.26 
Constant 6.01*** 0.24 
N Persons 444  
N Periods 1357  
συ 1.41  
Ρ 0.36  
 
 
Table 2: Predictions of Average Yearly Cost by Years 
Before Death With and Without Adjustment for Differential 
Hospital Costs  
Years Before Death Average Cost 
 Unadjusted Adjusted 
1 2754.57 3551.46 
2 1888.60 2023.37 
3 2066.76 2225.77 
4 1390.39 1477.63 
5 1220.00 1295.06 
6 1152.00 1222.76 
7 813.80 851.52 
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